28/05/2025

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

28/05/2025

May 28, 2025, 06:08 | Blog
ESMO Elections 2025 - Leadership Roles in Education, Policy, and Membership
European Society for Medical Oncology (ESMO) posted on X: "ESMO Members vote for the leaders…
May 28, 2025, 06:00 | Blog
Diego Díaz García Shares OptiTROP-Lung03 Trial Results at ASCO
Diego Díaz García, Medical Oncologist, CEO and Founder of CánCare, posted on X: "OptiTROP-Lung03 ASCO…
May 28, 2025, 05:52 | Blog
Applications are Open for ESO’s Refresher Course
European School of Oncology (ESO) posted on X: "Refine your approach to breast cancer care with…
May 28, 2025, 05:46 | Blog
Arndt Vogel: Epidemiology, Pathogenesis, Biology and Evolving Management of MSI-H/dMMR Cancers
Arndt Vogel, Managing Senior Consultant and a Professor in the Department of Gastroenterology, Hepatology, and…
May 28, 2025, 05:38 | Drugs
Sorafenib (Nexavar): What patients need to know?
Sorafenib is a targeted cancer treatment taken as a tablet. It has been approved by…
May 28, 2025, 04:13 | Blog
ASCO25 to Spotlight Evolving Standards in RCC and Urothelial Cancer Care
ASCO shared a post on X: "Recent years have seen updates to standards of care…
May 28, 2025, 03:50 | Insight
Patrizia Giannatempo: Phase 1/2 Duravelo-1 study
Patrizia Giannatempo, Medical Oncology Consultant at the National Cancer Institute (INT) in Milan, shared a…
May 28, 2025, 03:17 | Blog
Eric Singhi: Looking forward to discussing several of this year’s lung cancer oral abstracts at ASCO25
Eric Singhi, Thoracic Medical Oncologist at MD Anderson Cancer Center, shared a post on LinkedIn:…
May 28, 2025, 02:52 | Insight
Paolo Tarantino: Five review articles to read be ready for the practice changes in breast oncology expected from ASCO25
Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post on X: "Five review…
May 28, 2025, 02:31 | Blog
Jaume Capdevila: Great discussion on Neuroendocrine Cancer at ASCO25
Jaume Capdevila, Medical Oncologist at Vall d'Hebron University Hospital, shared a post on X: "Have…
All: 81 Posts: 71 - 80
Special Coverage